Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 563

Sort by

Sort Order Select

Journal Articles

How I treat microangiopathic hemolytic anemia in patients with cancer

M. R. Thomas, M. Scully

Blood (2021) 137 (10): 1310–1317.

https://doi.org/10.1182/blood.2019003810

Published: 2021

Journal Articles

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab

Sonata Jodele, Christopher E. Dandoy, Adam Lane, Benjamin L. Laskin, Ashley Teusink-Cross, Kasiani C. Myers, Gregory Wallace, Adam Nelson, Jack Bleesing, Ranjit S. Chima, Russel Hirsch, Thomas D. Ryan, Stefanie Benoit, Kana Mizuno, Mikako Warren, Stella M. Davies

Blood (2020) 135 (13): 1049–1057.

https://doi.org/10.1182/blood.2019004218

Published: 2020

Includes: Supplemental data

Journal Articles

Compliments to complement blockade for TA-TMA

Michael Scordo, Sergio Giralt

Blood (2020) 135 (13): 981–983.

https://doi.org/10.1182/blood.2020005040

Published: 2020

Journal Articles

Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome in Pregnancy: A Single Center Retrospective Review

Pallavi Kopparthy, MD, Anita Rajasekhar, MD

Blood (2019) 134 (Supplement_1): 4899.

https://doi.org/10.1182/blood-2019-131846

Published: 2019

Journal Articles

Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease

Ang Li, MD, Qian Vicky Wu, PhD, Tristan Hilton, Emily Pao, MS, Martin J Schmidt, PhD, Noel S Weiss, Stephanie J. Lee, MD MPH, Jingfei Dong, MD PhD, Sangeeta R Hingorani, MD MPH

Blood (2019) 134 (Supplement_1): 40.

https://doi.org/10.1182/blood-2019-128090

Published: 2019

Journal Articles

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Takuya Miyazaki, Ayako Matsumura, MD, Takayoshi Tachibana, Taiki Ando, MD, Megumi Koyama, MD, Satoshi Koyama, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Yuki Nakajima, MD, Ayumi Numata, MD, Wataru Yamamoto, MD, Kenji Motohashi, MD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD, Shin Fujisawa, MD, Hideaki Nakajima, MD

Blood (2019) 134 (Supplement_1): 1976.

https://doi.org/10.1182/blood-2019-123262

Published: 2019

Journal Articles

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Siddhesh Arun Kalantri, MD, Akanksha Chichra, DNB, Amit Kumar Agrawal, MDMDcine, Lingaraj Nayak, MDDM MDcal Oncology, Avinash Bonda, MD DM, Sachin Punatar, MBBS,MDDM MDcal Oncology, Anant Gokarn, MD, Bhausaheb Bagal, MD DM, Libin J Mathew, Sadhana Kannan, MSc, Navin Khattry, MD DM MDcal Oncology

Blood (2019) 134 (Supplement_1): 1983.

https://doi.org/10.1182/blood-2019-125029

Published: 2019

Journal Articles

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

Jeffrey Laurence, MD, Sonia Elhadad, PhD

Blood (2019) 134 (Supplement_1): 3676.

https://doi.org/10.1182/blood-2019-124158

Published: 2019

Journal Articles

Therapeutic Plasma Exchange (PLEX) in Thrombotic Microangiopathy (TMA): Experiences of an Inner-City Hospital over a Decade

Aakash Putta, MD MBBS, Hafeez Shaka, MD, Shristi Upadhyay Banskota, MD, Sunny R K Singh, MD, Sindhu Malapati, MD, Muhammad Zain Farooq, MD MBBS, Kumar Kunnal Batra, MD

Blood (2019) 134 (Supplement_1): 3691.

https://doi.org/10.1182/blood-2019-124265

Published: 2019

Journal Articles

P16, c-Myc, SOX11, P53, ki67 and CD71Protein Expression in Aggressive Morphological Variants of Mantle Cell Lymphomas Compared to Classical Morphological Mantle Cell Lymphomas in Multiple Clinical Trials

Barbara Burroni, Anne Moreau, MD, Mathieu Baldacini, MD, Antoine Martin, MD PhD, Steven Le Gouill, Vincent Ribrag, Rémy Gressin, MD, Chantal Brochet, Martin H. Dreyling, MD PhD, Samuel Griolet, Yannick Le Bris, PharmD, Morgane Cheminant, MD, Hanneke Kluin-Nelemans, MD, Olivier Hermine, MD PhD, Luc Mathieu Fornecker, MD PhD, Alexandra Traverse-Glehen, MD PhD, Danielle Canioni, MD

Blood (2019) 134 (Supplement_1): 2820.

https://doi.org/10.1182/blood-2019-129790

Published: 2019

Journal Articles

Validation of the Plasmic Score for Predicting ADAMTS13 Activity < 10% in Patients Admitted to Hospitals in Alberta with Suspected Thrombotic Thrombocytopenic Purpura

Chris Wynick, MD MSc, BSc, Joanne Britto, MD BSc, Daniel Sawler, MD BSc, Arabesque Parker, MD, Mohammad Karkhaneh, PhD, Dawn Goodyear, MD, Haowei Linda Sun, MDFRCPC

Blood (2019) 134 (Supplement_1): 2379.

https://doi.org/10.1182/blood-2019-126354

Published: 2019

Journal Articles

Plasma Exchange in Thrombotic Microangiopathy: Is It Time Sensitive?

Sindhu Malapati, MD, Sunny R K Singh, MD, Rohit Kumar, MD, Jason Mouabbi, MD, Tarik Hadid, MD MS

Blood (2019) 134 (Supplement_1): 2353.

https://doi.org/10.1182/blood-2019-129375

Published: 2019

Journal Articles

Host and Tumor Factor XII Drive Ovarian Cancer Maintenance and Progression

Evi X Stavrou, MD, Kara L. Bane, M.Sc., Peronne Joseph, M.Sc., Anil Belur Nagaraj, PhD, Analisa Difeo, PhD

Blood (2019) 134 (Supplement_1): 2384.

https://doi.org/10.1182/blood-2019-125862

Published: 2019

Journal Articles

Emicizumab Prophylaxis in Patients with Hemophilia Α with and without Inhibitors

Patrick T. Ebbert, BS, Frederico Xavier, MD MS, Craig D. Seaman, MD MS, Margaret V. Ragni, MD MPH

Blood (2019) 134 (Supplement_1): 2416.

https://doi.org/10.1182/blood-2019-123198

Published: 2019

Journal Articles

Highly Multiplexed Single Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Predicts Clinical Outcomes

Monirath Hav, PhD, Anthony Colombo, MS, Erik Gerdtsson, MS, Mohan Singh, PhD, Denaly Chen, MD, James Hicks, PhD, Peter Kuhn, PhD, Imran Siddiqi, MD PhD, Akil Merchant, MD

Blood (2019) 134 (Supplement_1): 2789.

https://doi.org/10.1182/blood-2019-130831

Published: 2019

Journal Articles

Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma

Patrizia Mondello, MD PhD MSc, Angelo Fama, MD, Melissa C Larson, Zhi-Zhang Yang, MD, Jose C Villasboas, Andrew L. Feldman, MD, Susan L Slager, PhD, Brian K. Link, MD, Sergei Syrbu, MD PhD, Anne J Novak, PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz Nowakowski, MD, James R. Cerhan, MD PhD, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 121.

https://doi.org/10.1182/blood-2019-126233

Published: 2019

Journal Articles

High Accuracy, Low-Cost Transcriptional Diagnostic to Transform Lymphoma Care in Low- and Middle-Income Countries

Edward Briercheck, MD, Fabiola Valvert, MD, Elizabeth Solorzano, MSc, Oscar Silva, MD PhD, Maneka Puligandla, MS, Marcos Mauricio Siliézar Tala, MD, Timothy Guyon, MSc, Samuel L. Dixon, BS, Robert Terbrueggen, PhD, Yasodha Natkunam, MD PhD, Kristen E. Stevenson, MS, David M Weinstock

Blood (2019) 134 (Supplement_1): 409.

https://doi.org/10.1182/blood-2019-121397

Published: 2019

Journal Articles

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 547.

https://doi.org/10.1182/blood-2019-121584

Published: 2019

Journal Articles

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Ethel Cesarman, MD PhD, Mikhail Roshal, MD PhD, Jonathan Reichel, PhD, Wagner Florian, PhD, Bhavneet Binder, Sakellarios Zairis, Jouliana Sadek, PhD, Joshua Brody, MD, Raul Rabadan, PhD, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 549.

https://doi.org/10.1182/blood-2019-131163

Published: 2019

Journal Articles

Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCL

Nicole Sunseri, MD PhD, Xiufen Chen, PhD, Noemie Wald, PhD, Julie Preillon, PhD, Sonali M. Smith, MD, Gregory Driessens, PhD, Justin Kline, MD

Blood (2019) 134 (Supplement_1): 391.

https://doi.org/10.1182/blood-2019-131493

Published: 2019

NARROW

How I treat microangiopathic hemolytic anemia in patients with cancer

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab

Compliments to complement blockade for TA-TMA

Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome in Pregnancy: A Single Center Retrospective Review

Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease

Predictive Values of Early ST2 for Acute Graft-Versus-Host Disease and Transplant-Related Complications after Allogeneic Stem Cell Transplantation

Pre-Transplant Use of Tyrosine Kinase Inhibitors Increases Risk of Transplant Associated Thrombotic Microangiopathy - a Single Centre Analysis of Incidence, Risk Factors and Outcomes

Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies

Therapeutic Plasma Exchange (PLEX) in Thrombotic Microangiopathy (TMA): Experiences of an Inner-City Hospital over a Decade

P16, c-Myc, SOX11, P53, ki67 and CD71Protein Expression in Aggressive Morphological Variants of Mantle Cell Lymphomas Compared to Classical Morphological Mantle Cell Lymphomas in Multiple Clinical Trials

Validation of the Plasmic Score for Predicting ADAMTS13 Activity < 10% in Patients Admitted to Hospitals in Alberta with Suspected Thrombotic Thrombocytopenic Purpura

Plasma Exchange in Thrombotic Microangiopathy: Is It Time Sensitive?

Host and Tumor Factor XII Drive Ovarian Cancer Maintenance and Progression

Emicizumab Prophylaxis in Patients with Hemophilia Α with and without Inhibitors

Highly Multiplexed Single Cell Spatial Analysis of the Tumor Microenvironment in Lymphoma Predicts Clinical Outcomes

Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma

High Accuracy, Low-Cost Transcriptional Diagnostic to Transform Lymphoma Care in Low- and Middle-Income Countries

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition

Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only